NCT03169998View on ClinicalTrials.gov

Effect of Goal-directed Fluid Therapy on Postoperative Complications

CompletedOBSERVATIONAL

Enrollment

375

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

September 30, 2021

Study Completion Date

December 31, 2021

Conditions

Liver DiseasesPancreas Disease

Interventions

DEVICE

EV1000 platform

a continuous arterial pressure monitoring was performed via EV1000/ FloTrac (Edwards Lifesciences, Irvine, CA, USA) (Fig 1) with the continuous monitoring of cardiac index (CI), stroke volume index (SVI) and stroke volume (SV).

Trial Locations (1)

463-707

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors

lead

Seoul National University Bundang Hospital

OTHER

NCT03169998 - Effect of Goal-directed Fluid Therapy on Postoperative Complications | Biotech Hunter | Biotech Hunter